RYDERY Peptide

The genus Shigella belongs to Gram-negative opportunistic human pathogens and is responsible for colonic infections.

Contributors

Inventor Institute
Andrzej Gamian ; Edmund Ziomek ; Danuta Witkowska ; Anna Ewelina Jarząb Polski O?rodek Rozwoju Technologii (PORT) Polish Center for Technology Development
Cat. #: 160578
Research Fields: Microbiology;Drug development;Immunology
Alternate name: Shigella flexneri 3a OMP
Product description: The genus Shigella belongs to Gram-negative opportunistic human pathogens and is responsible for colonic infections. Symptoms of infection include lower abdominal pain, fever and bloody diarrhoea which may cause a life threatening dehydration. Bacterial diarrhoea is in third place world wide in terms of causes of juvenile mortality below the age of five years. Infant and child mortality due to bacterial infections are generally caused by low standards of sanitation pervasive in developing nations. Nevertheless, infections by pathogenic intestinal bacteria, including Shigella, also occur in developed nations. Here, a bigger problem consists of strains resistant to antibiotics. For this reason, healthcare authorities both in developing and developed nations are pushing for prevention, including vaccination. Thus far, no one has managed to produce a vaccine against opportunistic bacterial pathogens of the gastrointestinal tract.
References:

Jarząb et al. 2013. PLoS One. 8(8):e70539. PMID: 23940590.

Related Tools for Proteins

Cat. # Tool Name
153951 rec-Tobacco Etch Virus protease Key Info View Tool
153953 Lichenase A Key Info View Tool
154133 CHEC-9 immunomodulatory Peptide Key Info View Tool
157649 NF712 peptide Key Info View Tool
153996 RAP as an LRP1 antagonist Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.